| Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations I Zerdes, A Matikas, J Bergh, GZ Rassidakis, T Foukakis Oncogene 37 (34), 4639-4661, 2018 | 285 | 2018 |
| Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells Q Lin, R Lai, LR Chirieac, C Li, VA Thomazy, I Grammatikakis, ... The American journal of pathology 167 (4), 969-980, 2005 | 282 | 2005 |
| Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma EJ Schlette, LJ Medeiros, A Goy, R Lai, GZ Rassidakis Journal of clinical oncology 22 (9), 1682-1688, 2004 | 270 | 2004 |
| AP-1 transcription factors as regulators of immune responses in cancer V Atsaves, V Leventaki, GZ Rassidakis, FX Claret Cancers 11 (7), 1037, 2019 | 254 | 2019 |
| Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma HM Amin, TJ McDonnell, Y Ma, Q Lin, Y Fujio, K Kunisada, V Leventaki, ... Oncogene 23 (32), 5426-5434, 2004 | 237 | 2004 |
| Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase–positive anaplastic large cell lymphoma F Vega, LJ Medeiros, V Leventaki, C Atwell, JH Cho-Vega, L Tian, ... Cancer research 66 (13), 6589-6597, 2006 | 236 | 2006 |
| Overexpression of CXCR4 predicts adverse overall and event‐free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype S Konoplev, GZ Rassidakis, E Estey, H Kantarjian, CI Liakou, X Huang, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 187 | 2007 |
| PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma V Atsaves, N Tsesmetzis, D Chioureas, L Kis, V Leventaki, E Drakos, ... Leukemia 31 (7), 1633-1637, 2017 | 179 | 2017 |
| Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma HM Amin, LJ Medeiros, Y Ma, M Feretzaki, P Das, V Leventaki, ... Oncogene 22 (35), 5399-5407, 2003 | 170 | 2003 |
| Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular … GV Georgakis, Y Li, GZ Rassidakis, H Martinez-Valdez, LJ Medeiros, ... Clinical cancer research 12 (2), 584-590, 2006 | 167 | 2006 |
| Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma E Peponi, E Drakos, G Reyes, V Leventaki, GZ Rassidakis, LJ Medeiros The American journal of pathology 169 (6), 2171-2180, 2006 | 163 | 2006 |
| Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma GV Georgakis, Y Li, GZ Rassidakis, LJ Medeiros, GB Mills, A Younes British journal of haematology 132 (4), 503-511, 2006 | 161 | 2006 |
| Differential Expression and Clinical Significance of Tyrosine-phosphorylated STAT3 in ALK+ and ALK− Anaplastic Large Cell Lymphoma JD Khoury, LJ Medeiros, GZ Rassidakis, MA Yared, P Tsioli, V Leventaki, ... Clinical cancer research 9 (10), 3692-3699, 2003 | 155 | 2003 |
| Characterization of 4 mantle cell lymphoma cell lines: establishment of an in vitro study model HM Amin, TJ McDonnell, LJ Medeiros, GZ Rassidakis, V Leventaki, ... Archives of pathology & laboratory medicine 127 (4), 424-431, 2003 | 154 | 2003 |
| MCL-1 expression in B-cell non-Hodgkin’s lymphomas JH Cho-Vega, GZ Rassidakis, JH Admirand, M Oyarzo, P Ramalingam, ... Human pathology 35 (9), 1095-1100, 2004 | 150 | 2004 |
| CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s disease: associations with presenting features and clinical outcome GZ Rassidakis, LJ Medeiros, S Viviani, V Bonfante, GP Nadali, ... Journal of Clinical Oncology 20 (5), 1278-1287, 2002 | 149 | 2002 |
| Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL ZY Xu-Monette, M Xiao, Q Au, R Padmanabhan, B Xu, N Hoe, ... Cancer immunology research 7 (4), 644-657, 2019 | 143 | 2019 |
| BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens GZ Rassidakis, LJ Medeiros, TP Vassilakopoulos, S Viviani, V Bonfante, ... Blood, The Journal of the American Society of Hematology 100 (12), 3935-3941, 2002 | 142 | 2002 |
| Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27Kip1 MA Kouvaraki, GZ Rassidakis, L Tian, R Kumar, C Kittas, FX Claret Cancer research 63 (11), 2977-2981, 2003 | 137 | 2003 |
| Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies N Herold, SG Rudd, L Ljungblad, K Sanjiv, IH Myrberg, CBJ Paulin, ... Nature medicine 23 (2), 256-263, 2017 | 130 | 2017 |